Literature DB >> 24990951

Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII.

Francesco Berti1, Edmondo Campisi2, Chiara Toniolo2, Laura Morelli2, Stefano Crotti2, Roberto Rosini2, Maria Rosaria Romano2, Vittoria Pinto2, Barbara Brogioni2, Giulia Torricelli2, Robert Janulczyk2, Guido Grandi2, Immaculada Margarit2.   

Abstract

The Group B Streptococcus capsular polysaccharide type IX was isolated and purified, and the structure of its repeating unit was determined. Type IX capsule → 4)[NeupNAc-α-(2 → 3)-Galp-β-(1 → 4)-GlcpNAc-β-(1 → 6)]-β-GlcpNAc-(1 → 4)-β-Galp-(1 → 4)-β-Glcp-(1 → appears most similar to types VII and V, although it contains two GlcpNAc residues. Genetic analysis identified differences in cpsM, cpsO, and cpsI gene sequences as responsible for the differentiation between the three capsular polysaccharide types, leading us to hypothesize that type V emerged from a recombination event in a type IX background.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Bacterial Genetics; Capsular Polysaccharide; Group B Streptococcus; Nuclear Magnetic Resonance; Polysaccharide; Streptococcus; Vaccine

Mesh:

Substances:

Year:  2014        PMID: 24990951      PMCID: PMC4156066          DOI: 10.1074/jbc.M114.567974

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.

Authors:  C E Rubens; M R Wessels; L M Heggen; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus.

Authors:  H J Jennings; K G Rosell; E Katzenellenbogen; D L Kasper
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

3.  Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus.

Authors:  H J Jennings; E Katzenellenbogen; C Lugowski; D L Kasper
Journal:  Biochemistry       Date:  1983-03-01       Impact factor: 3.162

4.  Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

Authors:  M R Wessels; L C Paoletti; D L Kasper; J L DiFabio; F Michon; K Holme; H J Jennings
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon.

Authors:  D O Chaffin; S B Beres; H H Yim; C E Rubens
Journal:  J Bacteriol       Date:  2000-08       Impact factor: 3.490

6.  Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.

Authors:  M R Wessels; C E Rubens; V J Benedí; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.

Authors:  C J Baker; D L Kasper
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

8.  Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide.

Authors:  H J Jennings; C Lugowski; D L Kasper
Journal:  Biochemistry       Date:  1981-08-04       Impact factor: 3.162

9.  The conformational epitope of type III group B Streptococcus capsular polysaccharide.

Authors:  W Zou; H J Jennings
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

10.  Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination.

Authors:  Kaihu Yao; Knud Poulsen; Domenico Maione; C Daniela Rinaudo; Lucilla Baldassarri; John L Telford; Uffe B Skov Sørensen; Mogens Kilian
Journal:  J Clin Microbiol       Date:  2012-11-28       Impact factor: 5.948

View more
  19 in total

1.  Streptococcus agalactiae capsule polymer length and attachment is determined by the proteins CpsABCD.

Authors:  Chiara Toniolo; Evita Balducci; Maria Rosaria Romano; Daniela Proietti; Ilaria Ferlenghi; Guido Grandi; Francesco Berti; Immaculada Margarit Y Ros; Robert Janulczyk
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

2.  Explaining the Serological Characteristics of Streptococcus suis Serotypes 1 and 1/2 from Their Capsular Polysaccharide Structure and Biosynthesis.

Authors:  Marie-Rose Van Calsteren; Guillaume Goyette-Desjardins; Fleur Gagnon; Masatoshi Okura; Daisuke Takamatsu; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  J Biol Chem       Date:  2016-02-24       Impact factor: 5.157

3.  Chemical Synthesis of the Repeating Unit of Type V Group B Streptococcus Capsular Polysaccharide.

Authors:  Jian Gao; Zhongwu Guo
Journal:  Org Lett       Date:  2016-10-19       Impact factor: 6.005

4.  Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide.

Authors:  Filippo Carboni; Roberto Adamo; Monica Fabbrini; Riccardo De Ricco; Vittorio Cattaneo; Barbara Brogioni; Daniele Veggi; Vittoria Pinto; Irene Passalacqua; Davide Oldrini; Rino Rappuoli; Enrico Malito; Immaculada Y Ros Margarit; Francesco Berti
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

5.  Contribution of murine IgG Fc regions to antibody binding to the capsule of Burkholderia pseudomallei.

Authors:  Michael J Dillon; Rachael A Loban; Dana E Reed; Peter Thorkildson; Kathryn J Pflughoeft; Sujata G Pandit; Paul J Brett; Mary N Burtnick; David P AuCoin
Journal:  Virulence       Date:  2016-04-20       Impact factor: 5.882

6.  The Group B Streptococcus-Secreted Protein CIP Interacts with C4, Preventing C3b Deposition via the Lectin and Classical Complement Pathways.

Authors:  Giampiero Pietrocola; Simonetta Rindi; Roberto Rosini; Scilla Buccato; Pietro Speziale; Immaculada Margarit
Journal:  J Immunol       Date:  2015-11-25       Impact factor: 5.422

7.  Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates.

Authors:  Edmondo Campisi; Roberto Rosini; Maria Rosaria Romano; Evita Balducci; Vittoria Pinto; Barbara Brogioni; Riccardo De Ricco; Monica Fabbrini; Angela Spagnuolo; Emiliano Chiarot; Francesco Berti; Immaculada Margarit
Journal:  Glycoconj J       Date:  2021-05-06       Impact factor: 2.916

8.  Characterization of host immunity during persistent vaginal colonization by Group B Streptococcus.

Authors:  K A Patras; B Rösler; M L Thoman; K S Doran
Journal:  Mucosal Immunol       Date:  2015-04-08       Impact factor: 7.313

9.  Real-time PCR-based serotyping of Streptococcus agalactiae.

Authors:  Kathleen M Breeding; Bhavana Ragipani; Kun-Uk David Lee; Martin Malik; Tara M Randis; Adam J Ratner
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

10.  Genomic Recombination Leading to Decreased Virulence of Group B Streptococcus in a Mouse Model of Adult Invasive Disease.

Authors:  Sarah Teatero; Paul Lemire; Ken Dewar; Jessica Wasserscheid; Cynthia Calzas; Gustavo V Mallo; Aimin Li; Taryn B T Athey; Mariela Segura; Nahuel Fittipaldi
Journal:  Pathogens       Date:  2016-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.